Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01565837
Title Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma
Acronym SART
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wolfram Samlowski
Age Groups: adult
Covered Countries USA

No variant requirements are available.